Koru Medical Systems, INC Form 4 insider transactions

NASDAQ
Joseph M. Manko Jr., a director and 10% owner of KORU Medical Systems, reported the acquisition of 5,870 shares and disposal of 517,200 shares of common stock on March 31, 2025.
NASDAQ
Linda Tharby, CEO of KORU Medical Systems, reports the vesting of restricted stock units and subsequent tax withholding, affecting her beneficial ownership.
NASDAQ
Christopher Pazdan, COO of Koru Medical Systems, reports the vesting and settlement of restricted stock units and performance share units, along with associated tax withholding.
NASDAQ
Kenneth E. Miller, Chief Commercial Officer of KORU Medical Systems, reports the vesting of restricted stock units and subsequent tax withholding.
NASDAQ
Thomas Edward Adams, CFO of Koru Medical Systems, reports the vesting of restricted stock units and subsequent tax withholding.
NASDAQ
Horton Capital Partners Fund, L.P. distributed 16,187 shares of KORU Medical Systems, Inc. common stock to its limited partners on February 6, 2025.
NASDAQ
Joseph M. Manko Jr., a director and 10% owner of Koru Medical Systems, reported a series of share transfers involving Horton Capital entities, resulting in a net change in his direct and indirect holdings.
NASDAQ
Director Shahriar Matin acquired 3,937 shares of KORU Medical Systems at $3.81 per share on January 3, 2025, increasing his direct holdings to 77,545 shares.
NASDAQ
Director Edward Wholihan of KORU Medical Systems, Inc. reports acquiring 3,937 shares of common stock at $3.81 per share on January 3, 2025.
NASDAQ
Director Robert Cascella of KORU Medical Systems, Inc. reports the acquisition of 3,937 shares of common stock at $3.81 per share on January 3, 2025.
NASDAQ
John Fletcher, a director at Koru Medical Systems, reported acquiring 5,905 shares of common stock at $3.81 per share on January 3, 2025.
NASDAQ
Director Donna French of KORU Medical Systems, Inc. reports acquiring 3,937 shares of common stock at $3.81 per share on January 3, 2025.
NASDAQ
Joseph M. Manko Jr., a director of KORU Medical Systems, received 3,937 shares of common stock for his board service during the quarter ended December 31, 2024, while Horton Capital Partners Fund, LP, disposed of 165,252 shares.
NASDAQ
A Koru Medical Systems director amended a previous SEC filing to correct the number of shares beneficially owned following a transaction.
NASDAQ
A Koru Medical Systems director amended a previous SEC filing to correct the number of shares beneficially owned following a recent transaction.
NASDAQ
Director Edward Wholihan of KORU Medical Systems reports the acquisition and disposal of common stock on October 1, 2024.
NASDAQ
Director Shahriar Matin reports acquisition of 5,454 shares of KORU Medical Systems at $2.75 per share on October 1, 2024.
NASDAQ
Director Donna French of KORU Medical Systems, Inc. acquired 5,454 shares of common stock at $2.75 per share on October 1, 2024.
NASDAQ
Director John Fletcher acquired 8,181 shares of KORU Medical Systems at $2.75 per share on October 1, 2024.
NASDAQ
Director Robert Cascella acquired 5,454 shares of KORU Medical Systems at $2.75 per share on October 1, 2024.
NASDAQ
Joseph M. Manko, Jr., a director of KORU Medical Systems, received 5,454 shares of common stock for his service during the quarter ended September 30, 2024.
NASDAQ
CEO Linda Tharby reports the acquisition of restricted stock units and stock options in KORU Medical Systems.
NASDAQ
Chief Operating Officer Christopher Pazdan reports the acquisition of restricted stock units and options in KORU Medical Systems, Inc.
NASDAQ
Kenneth E. Miller, Chief Commercial Officer of KORU Medical Systems, reports the acquisition of restricted stock units and stock options in a recent Form 4 filing.
NASDAQ
Chief Financial Officer of KORU Medical Systems, Thomas Edward Adams, reports the acquisition of restricted stock units and stock options.
NASDAQ
Horton Capital Partners Fund, L.P. distributed 721,781 shares of KORU Medical Systems, Inc. common stock to its limited partners on July 24, 2024.
NASDAQ
Joseph M. Manko, Jr., a director of KORU Medical Systems, received 5,545 shares of common stock for his service as a director for the quarter ended June 30, 2024.
NASDAQ
Director Edward Wholihan reports acquisition of 5,545 shares of Koru Medical Systems at $2.71 per share and disposal of 18,322 shares.
NASDAQ
Director Shahriar Matin acquired 5,545 shares of Koru Medical Systems, Inc. at a price of $2.71 on July 11, 2024, increasing his total holdings to 68,154 shares.
NASDAQ
Director Donna French acquired 5,545 shares of Koru Medical Systems at $2.71 per share on July 11, 2024.